McKesson logged a 1.6% change during today's afternoon session, and is now trading at a price of $460.03 per share. On average, analysts give it a target price of $486.33.
McKesson Corporation provides healthcare services in the United States and internationally. The large-cap company is based in the United States. McKesson currently returns an annual dividend yield of 0.5%.
What to Consider if You Are Thinking of Buying McKesson:
-
McKesson has moved 17.0% over the last year.
-
MCK has a forward P/E ratio of 15.0 based on its EPS guidance of 30.68.
-
Over the last 6 years, earnings per share (EPS) have been growing at a compounded average rate of 106.8%.
-
The company has a price to earnings growth (PEG) ratio of 1.67.
McKesson Has Irregular Cash Flows
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2023 | 5,159,000 | 390,000 | 4,769,000 | 17.87 |
| 2022 | 4,434,000 | 388,000 | 4,046,000 | -1.1 |
| 2021 | 4,542,000 | 451,000 | 4,091,000 | 1.97 |
| 2020 | 4,374,000 | 362,000 | 4,012,000 | 11.14 |
| 2019 | 4,036,000 | 426,000 | 3,610,000 | -8.38 |
| 2018 | 4,345,000 | 405,000 | 3,940,000 |
McKesson's free cash flows have a decent average of $4.08 Billion over the last 6 years, but they are highly variable since their coefficient of variability is 288.1%. The compounded average growth rate over this period is 3.2%.
